HC Surgical Specialists Limited (SGX:1B1)

HC Surgical Specialists Income Statement

Financials in millions SGD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021
Operating Revenue	18.94	19.11	18.81	19.08	19.31	23.36
Other Revenue	0.19	0.19	0.16	0.17	0.11	0.11
Revenue	19.14	19.3	18.97	19.25	19.42	23.47
Revenue Growth (YoY)	-0.78%	1.77%	-1.48%	-0.86%	-17.25%	38.95%
Cost of Revenue	10.67	10.38	9.89	9.28	9.48	10.61
Gross Profit	8.47	8.92	9.08	9.98	9.94	12.86
Selling, General & Admin	0.03	0.03	0.02	0.02	0.06	-0.16
Other Operating Expenses	1.53	1.53	1.59	2.26	1.49	2.11
Operating Expenses	3.59	3.49	3.65	4.03	3.22	3.66
Operating Income	4.88	5.43	5.43	5.95	6.72	9.2
Interest Expense	-0.12	-0.26	-0.5	-0.64	-0.47	-0.21
Interest & Investment Income	0.52	0.54	0.77	0.82	0.82	0.48
Earnings From Equity Investments	0.63	0.78	-0.09	-	-	-
Other Non Operating Income (Expenses)	2.08	1.84	-0.45	0.29	0.53	-0.09
EBT Excluding Unusual Items	7.99	8.34	5.16	6.42	7.59	9.39
Merger & Restructuring Charges	-0.02	-0.02	-	-	-	-
Impairment of Goodwill	-	-	-	-0.68	-0.75	-
Gain (Loss) on Sale of Investments	1.47	0.49	-0.06	-1.62	0.99	0.31
Gain (Loss) on Sale of Assets	-	-	-	0	-0.02	0
Asset Writedown	0.02	-0	-0.16	-0.13	-0.07	-0
Other Unusual Items	-	-	0.12	0.06	-0.01	0.57
Pretax Income	9.46	8.8	5.06	4.05	7.75	10.27
Income Tax Expense	0.26	0.02	1.12	1.07	0.94	1.41
Earnings From Continuing Operations	9.2	8.78	3.94	2.99	6.8	8.85
Minority Interest in Earnings	-0.17	-0.34	-0.09	-0.07	-0.42	-0.85
Net Income	9.03	8.44	3.85	2.92	6.38	8
Net Income to Common	9.03	8.44	3.85	2.92	6.38	8
Net Income Growth	139.18%	119.42%	31.76%	-54.25%	-20.25%	100.65%
Shares Outstanding (Basic)	153	154	152	149	149	150
Shares Outstanding (Diluted)	153	154	152	149	149	150
Shares Change (YoY)	-0.20%	0.94%	2.28%	-	-0.72%	0.02%
EPS (Basic)	0.06	0.05	0.03	0.02	0.04	0.05
EPS (Diluted)	0.06	0.05	0.03	0.02	0.04	0.05
EPS Growth	139.63%	117.39%	28.82%	-54.25%	-19.68%	100.61%
Free Cash Flow	6.95	6.75	6.23	6.51	6.84	10.24
Free Cash Flow Per Share	0.04	0.04	0.04	0.04	0.05	0.07
Dividend Per Share	0.021	0.020	0.014	0.020	0.026	0.040
Dividend Growth	38.67%	41.43%	-30.00%	-23.08%	-35.00%	100.00%
Gross Margin	44.27%	46.23%	47.87%	51.81%	51.18%	54.81%
Operating Margin	25.49%	28.13%	28.62%	30.88%	34.59%	39.20%
Profit Margin	47.18%	43.72%	20.28%	15.16%	32.85%	34.09%
Free Cash Flow Margin	36.30%	34.95%	32.85%	33.82%	35.20%	43.63%
EBITDA	5.35	5.87	5.92	6.39	7.22	9.69
EBITDA Margin	27.94%	30.40%	31.24%	33.17%	37.20%	41.30%
D&A For EBITDA	0.47	0.44	0.5	0.44	0.51	0.49
EBIT	4.88	5.43	5.43	5.95	6.72	9.2
EBIT Margin	25.49%	28.13%	28.62%	30.88%	34.59%	39.20%
Effective Tax Rate	2.74%	0.24%	22.17%	26.35%	12.19%	13.77%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.